Ketamine Increases Proliferation of Human iPSC-Derived Neuronal Progenitor Cells via Insulin-Like Growth Factor 2 and Independent of the NMDA Receptor

Please use this identifier to cite or link to this item:
https://nbn-resolving.org/urn:nbn:de:gbv:700-202004202858
Open Access logo originally created by the Public Library of Science (PLoS)
Title: Ketamine Increases Proliferation of Human iPSC-Derived Neuronal Progenitor Cells via Insulin-Like Growth Factor 2 and Independent of the NMDA Receptor
Authors: Grossert, Alessandra
Mehrjardi, Narges Zare
Bailey, Sarah J.
Lindsay, Mark A.
Hescheler, Jürgen
Šarić, Tomo
Teusch, Nicole
ORCID of the author: https://orcid.org/0000-0001-8344-1095
https://orcid.org/0000-0002-9030-1493
Abstract: The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine offers promising perspectives for the treatment of major depressive disorder. Although ketamine demonstrates rapid and long-lasting effects, even in treatment-resistant patients, to date, the underlying mode of action remains elusive. Thus, the aim of our study was to investigate the molecular mechanism of ketamine at clinically relevant concentrations by establishing an in vitro model based on human induced pluripotent stem cells (iPSCs)-derived neural progenitor cells (NPCs). Notably, ketamine increased the proliferation of NPCs independent of the NMDA receptor, while transcriptome analysis revealed significant upregulation of insulin-like growth factor 2 (IGF2) and p11, a member of the S100 EF-hand protein family, which are both implicated in the pathophysiology of depression, 24 h after ketamine treatment. Ketamine (1 µM) was able to increase cyclic adenosine monophosphate (cAMP) signaling in NPCs within 15 min and cell proliferation, while ketamine-induced IGF2 expression was reduced after PKA inhibition with cAMPS-Rp. Furthermore, 24 h post-administration of ketamine (15 mg/kg) in vivo confirmed phosphorylation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) in the subgranular zone (SGZ) of the hippocampus in C57BL/6 mice. In conclusion, ketamine promotes the proliferation of NPCs presumably by involving cAMP-IGF2 signaling.
Citations: Cells 2019, 8(10), 1139
URL: https://repositorium.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202004202858
Subject Keywords: human iPSC-derived NPCs; depression; neurogenesis; ketamine; IGF2; cAMP; p11
Issue Date: 24-Sep-2019
License name: Attribution 4.0 International
License url: http://creativecommons.org/licenses/by/4.0/
Type of publication: Einzelbeitrag in einer wissenschaftlichen Zeitschrift [article]
Appears in Collections:FB08 - Hochschulschriften
Open-Access-Publikationsfonds

Files in This Item:
File Description SizeFormat 
Cells_2019_08_1139_Grossert.pdf4,48 MBAdobe PDF
Cells_2019_08_1139_Grossert.pdf
Thumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons